Pre-eclampsia causes: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Sara Zand (talk | contribs)
11,403 edits
Sam Norris (talk | contribs)
Bureaucrats, bureaucrats, editnews, exportpages, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
260 edits
No edit summary
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pre-eclampsia}}
{{Pre-eclampsia}}
{{CMG}}; {{AE}} {{Ochuko}}
{{CMG}}; {{AE}} {{Sara.Zand}} {{Ochuko}}
==Overview==
Common causes of [[preeclampsia]] include [[uteroplacental ischemia]] and [[genetic]] predisposition following the formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[spiral]] [[vessel walls]], [[oxidative stress]] in [[trophoblast cells]], [[apoptosis]] in [[trophoblast cells]],[[systemic inflammatory response]], [[vasospasm]], [[platelet]] aggregation, [[thrombin]] formation, deposition of the [[fibrin]] in multiple [[organs]].
 
==Causes==
==Causes==
 
Common cause of [[preeclampsia]] include [[uteroplacental]] [[ischemia]] and [[genetic predisposition]] due to the following:<ref name="LyeBloise2013">{{cite journal|last1=Lye|first1=P.|last2=Bloise|first2=E.|last3=Dunk|first3=C.|last4=Javam|first4=M.|last5=Gibb|first5=W.|last6=Lye|first6=S.J.|last7=Matthews|first7=S.G.|title=Effect of oxygen on multidrug resistance in the first trimester human placenta|journal=Placenta|volume=34|issue=9|year=2013|pages=817–823|issn=01434004|doi=10.1016/j.placenta.2013.05.010}}</ref><ref name="MayrinkCosta2018">{{cite journal|last1=Mayrink|first1=J.|last2=Costa|first2=M. L.|last3=Cecatti|first3=J. G.|title=Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction|journal=The Scientific World Journal|volume=2018|year=2018|pages=1–9|issn=2356-6140|doi=10.1155/2018/6268276}}</ref>
Common cause of [[preeclampsia]] include [[uteroplacental ischemia]] and [[genetic predisposition]] due to the following:<ref name="LyeBloise2013">{{cite journal|last1=Lye|first1=P.|last2=Bloise|first2=E.|last3=Dunk|first3=C.|last4=Javam|first4=M.|last5=Gibb|first5=W.|last6=Lye|first6=S.J.|last7=Matthews|first7=S.G.|title=Effect of oxygen on multidrug resistance in the first trimester human placenta|journal=Placenta|volume=34|issue=9|year=2013|pages=817–823|issn=01434004|doi=10.1016/j.placenta.2013.05.010}}</ref>
   
   
* The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[vessel walls]]
* The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[spiral]] [[vessel walls]]
* [[Oxidative stress]] in [[trophoblast cells]]
* [[Oxidative stress]] in [[trophoblast cells]]
* [[apoptosis]] in [[trophoblast cells]]
* [[Apoptosis]] in [[trophoblast cells]]
* [[Systemic inflammatory response]]
* [[Systemic inflammatory response]]
* [[vasospasm]]
* [[Vasospasm]]
*[[Platelet]] aggreggation]]
* [[Platelet]] aggregation
* [[thrombin formation]]
* [[Thrombin]] formation
* Deposition of the [[fibrin]] in multiple [[organs]]
* Deposition of the [[fibrin]] in multiple [[organs]]
In these cases, the arteries undergo a
process of atherosis with very similar results to the formation
of atheromatous plaques, with their lumens invaded by lipidrich
macrophages, perivascular mononuclear inflammatory
infiltrate, and fibrinoid necrosis of the vessel walls, with
consequent uteroplacental ischemia.Then, a vicious circle of
ischemia and reperfusion in the intervillous space is installed,
with the metabolic stress of the endoplasmic reticulum
of the trophoblast cells, which are structures responsible
for cellular homeostasis and, ultimately, for the apoptosis
of the same. This process releases nanomolecules into the
maternal circulation, which is capable of triggering a broad
intravascular inflammatory response, an essential step for the
development of preeclampsia [33], as well as free radicals,
in consequence of the extensive oxidative stress and the
collapse of placental mechanisms and antioxidants enzymes
[36]. It can be said that such a process is immunomediated,
as it involves systemic inflammatory response and maternal
genetic predisposition [34, 36, 37].
Theaforementioned oxidative stress, aswell as the cellular
apoptosis, would be determinant for an imbalance between
proangiogenic and antiangiogenic factors, with a predominance
of the latter [37]. Increased concentrations of VEGFR-1
(capable of blocking the angiogenic action of VEGF) and the
soluble form of this vascular endothelial growth factor, sFlt-
1(fms-like tyrosine kinase 1), a potent antagonist of VEGF
action, and decreased synthesis of placental growth factor
(PlGF) are associated with the predominance of antiangiogenic
elements characteristic of preeclampsia [37, 38].
Finally, the understanding of the pathophysiology of
preeclampsia, even though it is partial, includes the activation
and consequent platelet consumption at levels above those
observed in normal pregnancies, vasospasm, and prostacyclin
deficiency that have a vasodilatory action and inhibit
platelet aggregation. Otherwise, the synthesis of thromboxane
A2 is increased in placentas of women with preeclampsia,
which determines the predominance of vasoconstriction and
increased platelet aggregation [39], as well as thrombin,
which has its maximum expression in disseminated intravascular
coagulation, clinically translated to placental abruption
[40]. Bigger synthesis of thrombin is part of a more vigorous
inflammatory response characteristic of preeclampsia, as
already exposed above, and determines the deposition of
fibrin in multiple organs, which reinforces the systemic
character of the pathological condition.
The pre-eclampsia syndrome is thought in some cases to be caused by a shallowly implanted placenta which becomes hypoxic, leading to upregulated [[inflammatory]] mediators secreted by the [[placenta]] and acting on the vascular [[endothelium]].  The shallow implantation is thought to stem from the maternal system's response to the placenta.  But in some cases of preeclampsia, the placenta appears to have implanted normally.  Possibly women with higher baseline levels of inflammation stemming from underlying conditions such as chronic hypertension may have normally implanted placentae, but less tolerance for the inflammatory burden of pregnancy. 
If severe, preeclampsia progresses to ''fulminant pre-eclampsia,'' with [[headache]]s, visual disturbances, and epigastric pain, and further to [[HELLP syndrome]] and[[eclampsia]].  [[Placental abruption]] is associated with hypertensive pregnancies.  These are [[medical emergency|life-threatening conditions]] for both the developing baby and the mother.
Many theories have attempted to explain why the pre-eclampsia syndrome arises in some pregnancies:
* [[Vitamin D deficiency]] 
* Endothelial cell injury
* Rejection phenomenon
* Compromised placental perfusion
* Altered vascular reactivity
* Imbalance between [[prostacyclin]] and [[thromboxane]]
* Decreased [[glomerular filtration rate]] with retention of salt and water
* Decreased intravascular volume
* Increased central nervous system irritability
* [[Disseminated intravascular coagulation]]
* Uterine muscle stretch ([[ischemia]])
* Dietary factors
* Genetic factors<ref name=AMN>{{cite web | author =Courtney Reynolds, MD, William C. Mabie, MD, & Baha M. Sibai, MD | title =Preeclampsia | publisher=Armenian Medical Network |work =Pregancy - Hypertensive Disorders | url=http://www.health.am/pregnancy/preeclampsia/ | year = 2006 | accessdate=2006-11-23}}</ref>
The current understanding of the disease is as a two-stage process, with a variable first stage which predisposes the [[placenta]] to [[hypoxia]], followed by the release of soluble factors which result in many of the other observed phenomena.  Many of the older theories can be subsumed under this umbrella, as the soluble factors have been shown to cause, for example, endothelial cell injury, altered vascular reactivity, the classic lesion of glomerular endotheliosis, decreased intravascular volume, etc.  Underlying maternal susceptibility to the damage is likely implicated as well.


==References==
==References==
Line 97: Line 25:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Needs overview]]
[[Category:Up-to-date]]
 
{{WH}}
{{WS}}

Latest revision as of 14:51, 4 March 2021

Pre-eclampsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pre-eclampsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pre-eclampsia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pre-eclampsia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pre-eclampsia causes

CDC on Pre-eclampsia causes

Pre-eclampsia causes in the news

Blogs on Pre-eclampsia causes

Directions to Hospitals Treating Pre-eclampsia

Risk calculators and risk factors for Pre-eclampsia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ogheneochuko Ajari, MB.BS, MS [3]

Overview

Common causes of preeclampsia include uteroplacental ischemia and genetic predisposition following the formation of atheromatous plaques and fibrinoid necrosis of the spiral vessel walls, oxidative stress in trophoblast cells, apoptosis in trophoblast cells,systemic inflammatory response, vasospasm, platelet aggregation, thrombin formation, deposition of the fibrin in multiple organs.

Causes

Common cause of preeclampsia include uteroplacental ischemia and genetic predisposition due to the following:[1][2]

References

  1. ↑ Lye, P.; Bloise, E.; Dunk, C.; Javam, M.; Gibb, W.; Lye, S.J.; Matthews, S.G. (2013). "Effect of oxygen on multidrug resistance in the first trimester human placenta". Placenta. 34 (9): 817–823. doi:10.1016/j.placenta.2013.05.010. ISSN 0143-4004.
  2. ↑ Mayrink, J.; Costa, M. L.; Cecatti, J. G. (2018). "Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction". The Scientific World Journal. 2018: 1–9. doi:10.1155/2018/6268276. ISSN 2356-6140.
Retrieved from "https://www.wikidoc.org/index.php?title=Pre-eclampsia_causes&oldid=1693161"